The drug, called ketamine, has already been shown to help when given intravenously. Developers tried a nasal spray formulation that they thought might act more quickly and be easier to give.
The hope is to help patients hold on until more traditional anti-depressants and therapy have a chance to click in, developers said.
More
from Salisbury News https://ift.tt/2HyVczu
ليست هناك تعليقات:
إرسال تعليق